Jundishapur Journal of Microbiology

Published by: Kowsar

Antibiotic Resistance Trends and The ESBL Prevalence of Escherichia coli and Klebsiella spp Urinary Isolates in In-and Outpatients in a Tertiary Care Hospital in Istanbul, 2004 - 2012

Seniha Senbayrak 1 , * , Efe Serkan Boz 2 , Simin Cevan 3 , Asuman Inan 1 , Derya Ozturk Engin 1 , Nilgun Dosoglu 2 , Naz Cobanoglu 2 , Ozgur Dagli 4 , Ismail Davarci 5 and Sebahat Aksaray 2
Authors Information
1 Department of Infectious Diseases and Clinical Microbiology Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
2 Department of Microbiology and Clinical Microbiology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey
3 Public Health Laboratory, Bolu, Turkey
4 Department of Infectious Diseases and Clinical Microbiology, Bursa Sevket Yilmaz Training and Research Hospital, Bursa, Turkey
5 Department of Microbiology and Clinical Microbiology, Goztepe Training and Research Hospital, Istanbul, Turkey
Article information
  • Jundishapur Journal of Microbiology: May 2017, 10 (5); e13098
  • Published Online: May 17, 2017
  • Article Type: Research Article
  • Received: November 16, 2016
  • Revised: April 5, 2017
  • Accepted: April 5, 2017
  • DOI: 10.5812/jjm.13098

To Cite: Senbayrak S, Serkan Boz E, Cevan S, Inan A, Ozturk Engin D, et al. Antibiotic Resistance Trends and The ESBL Prevalence of Escherichia coli and Klebsiella spp Urinary Isolates in In-and Outpatients in a Tertiary Care Hospital in Istanbul, 2004 - 2012, Jundishapur J Microbiol. 2017 ; 10(5):e13098. doi: 10.5812/jjm.13098.

Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Stamm WE, Norrby SR. Urinary tract infections: disease panorama and challenges. J Infect Dis. 2001; 183 Suppl 1-4[DOI][PubMed]
  • 2. van der Kooi TI, Mannien J, Wille JC, van Benthem BH. Prevalence of nosocomial infections in The Netherlands, 2007-2008: results of the first four national studies. J Hosp Infect. 2010; 75(3): 168-72[DOI][PubMed]
  • 3. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009; 34(5): 407-13[DOI][PubMed]
  • 4. Rodriguez-Bano J, Alcala JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med. 2008; 168(17): 1897-902[DOI][PubMed]
  • 5. Apisarnthanarak A, Kiratisin P, Mundy LM. Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2008; 29(7): 671-4[DOI][PubMed]
  • 6. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008; 13(47)[PubMed]
  • 7. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8(3): 159-66[DOI][PubMed]
  • 8. Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries. 2009; 3(4): 295-9[PubMed]
  • 9. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect. 2009; 73(4): 345-54[DOI][PubMed]
  • 10. Wayne PA. Performance standards for antimicrobial susceptibility testing. 2007;
  • 11. Empel J, Baraniak A, Literacka E, Mrowka A, Fiett J, Sadowy E, et al. Molecular survey of beta-lactamases conferring resistance to newer beta-lactams in Enterobacteriaceae isolates from Polish hospitals. Antimicrob Agents Chemother. 2008; 52(7): 2449-54[DOI][PubMed]
  • 12. Luzzaro F, Mezzatesta M, Mugnaioli C, Perilli M, Stefani S, Amicosante G, et al. Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J Clin Microbiol. 2006; 44(5): 1659-64[DOI][PubMed]
  • 13. Galas M, Decousser JW, Breton N, Godard T, Allouch PY, Pina P, et al. Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France. Antimicrob Agents Chemother. 2008; 52(2): 786-9[DOI][PubMed]
  • 14. Abreu AG, Marques SG, Monteiro-Neto V, Carvalho RM, Goncalves AG. Nosocomial infection and characterization of extended-spectrum beta-lactamases-producing Enterobacteriaceae in Northeast Brazil. Rev Soc Bras Med Trop. 2011; 44(4): 441-6[PubMed]
  • 15. Isikgoz Tasbakan M, Durusoy R, Pullukcu H, Sipahi OR, Ulusoy S, Turkish Nosocomial Urinary Tract Infection Study G. Hospital-acquired urinary tract infection point prevalence in Turkey: differences in risk factors among patient groups. Ann Clin Microbiol Antimicrob. 2013; 12: 31[DOI][PubMed]
  • 16. Demir T, Buyukguclu T. Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey. Int J Infect Dis. 2013; 17(11)-70[DOI][PubMed]
  • 17. Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, et al. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin Microbiol Infect. 2010; 16(2): 147-51[DOI][PubMed]
  • 18. den Heijer CD, Donker GA, Maes J, Stobberingh EE. Antibiotic susceptibility of unselected uropathogenic Escherichia coli from female Dutch general practice patients: a comparison of two surveys with a 5 year interval. J Antimicrob Chemother. 2010; 65(10): 2128-33[DOI][PubMed]
  • 19. Abreu AG, Marques SG, Monteiro-Neto V, Goncalves AG. Extended-spectrum beta-lactamase-producing enterobacteriaceae in community-acquired urinary tract infections in Sao Luis, Brazil. Braz J Microbiol. 2013; 44(2): 469-71[DOI][PubMed]
  • 20. Aykan SB, Ciftci IH. [Antibiotic resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a meta-analysis]. Mikrobiyol Bul. 2013; 47(4): 603-18[PubMed]
  • 21. Qiao LD, Chen S, Yang Y, Zhang K, Zheng B, Guo HF, et al. Characteristics of urinary tract infection pathogens and their in vitro susceptibility to antimicrobial agents in China: data from a multicenter study. BMJ Open. 2013; 3(12)[DOI][PubMed]
  • 22. Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Res Notes. 2010; 3: 348[DOI][PubMed]
  • 23. Kronenberg A, Hilty M, Endimiani A, Muhlemann K. Temporal trends of extended-spectrum cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolates in in- and outpatients in Switzerland, 2004 to 2011. Euro Surveill. 2013; 18(21)[PubMed]
  • 24. Schmiemann G, Gagyor I, Hummers-Pradier E, Bleidorn J. Resistance profiles of urinary tract infections in general practice--an observational study. BMC Urol. 2012; 12: 33[DOI][PubMed]
  • 25. Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect Dis. 2013; 13: 19[DOI][PubMed]
  • 26. Koningstein M, van der Bij AK, de Kraker ME, Monen JC, Muilwijk J, de Greeff SC, et al. Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands. PLoS One. 2014; 9(1)[DOI][PubMed]
  • 27. Arslan H, Azap OK, Ergonul O, Timurkaynak F, Urinary Tract Infection Study G. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey. J Antimicrob Chemother. 2005; 56(5): 914-8[DOI][PubMed]
  • 28. Erdem H. , Avci, A. , Pahsa, A. . Toplum kaynakli uropatojenik Escherichia coli suslarinda antibakteriyel direnc. ANKEM Derg. 2004; 18: 40-4
  • 29. Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes. 2013; 6: 487[DOI][PubMed]
  • 30. Tinelli M, Cataldo MA, Mantengoli E, Cadeddu C, Cunietti E, Luzzaro F, et al. Epidemiology and genetic characteristics of extended-spectrum beta-lactamase-producing Gram-negative bacteria causing urinary tract infections in long-term care facilities. J Antimicrob Chemother. 2012; 67(12): 2982-7[DOI][PubMed]
  • 31. Coskun O, Erdem H, Avci A. Management of community-acquired acute bacterial cystitis in Turkey. Turk J Med Sci. 2011; 41(1): 149-57
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments